Pyramus

30 ms·

271.
by Pyramus 5y ago
I don't think you have to go all the way to plastics and chemicals (not saying that they aren't potentially playing their part). Take a simple model with a combination of all the factors the author discusses (type of diet, sugar,
272.
by Pyramus 5y ago
This issue caught my eye as well, and I find the argumentation quite sloppy in some parts. Also see my other post https://news.ycombinator.com/item?id=27808936 Now take several of these "insignificant" factors, ad
273.
by Pyramus 5y ago
This series of blog posts is a fascinating read into conjectured factors behind the obesity epidemic. I wish the author had continued their rigor in reasoning throughout the two blog posts. Step by step the author is lured into proving a si
274.
by Pyramus 5y ago
Well Germany did bend over to Wirecard quite a bit and as a result facilitated the success of a large tech company.
275.
by Pyramus 5y ago
In general yes, applications and permits are public documents. I'm not 100% sure about rejections though (maybe somebody can chime in) but in any case you can infer it from the diff of application and permit. Publicly available does no
276.
by Pyramus 5y ago
> I have yet to find a source that gives the risk for that cohort. The data is publicly available for many countries, e.g. here for the UK: [1] Report on adverse reactions until 16 Jun 2021 https://www.gov.uk/government&#
277.
by Pyramus 5y ago
Again, that is false. It's not even close, for women age 20-29 the risk of fatal thrombosis is 1:250k, while Covid is somewhere around 1:25k [1]. That's a whole order of magnitude. The risk/benefit ratio of AZ vaccine is only
278.
by Pyramus 5y ago
I don't think anyone is ignoring these issues - on the contrary, even in these very rare cases of side effects vaccination efforts were halted immediately. Safe is always relative. If you don't think the vaccines are safe enough,
279.
by Pyramus 5y ago
I don't follow your argumentation - why would extremely high antibody titres not almost certainly result in a better immune response? On the contrary, from all that we know today, wouldn't we expect people with high IgA titres to
280.
by Pyramus 5y ago
Exactly, and the scary thing is not only do we emit more carbon every year, the rate of emission is also increasing, i.e. we are still on an exponential growth curve.
281.
by Pyramus 5y ago
> But technology is never the problem, politics is. I agree with you argumentation but I do not see why 'some/many technological problems are political problems' means 'all technological problems are political problem
282.
by Pyramus 5y ago
> We don't have access to US-style stonk options Could you clarify please? There are a number of brokers that give you access to US option markets in Germany, e.g. all the intermediaries for Interactive Brokers such as Lynx, Banx, e
283.
by Pyramus 5y ago
That's a completely different discussion whether the strategy was the right strategy in the first place, and unrelated to my argument. What I'm saying is that given the current situation, player A (OP) loses nothing while player B
284.
by Pyramus 5y ago
That's exactly right. As of today, some virologists think that we are already seeing early signs of convergence among virus variants, i.e. the same mutations appearing in different variants. It's early speculation and there is no
285.
by Pyramus 5y ago
Is there any indication that the WHO vaccination passport will stop to be good enough? It seems to me this is just a question of convenience.
286.
by Pyramus 5y ago
Yes, in rare cases that might happen but in general that sounds like a trope. In fact, I've heard stories of people being denied entry and also getting vaccinated on arrival in a back room at the airport, which is as dodgy as it sounds
287.
by Pyramus 5y ago
> Seems like a question of reciprocity and solidarity. I have to disagree here. There is neither reciprocity nor solidarity involved, because you gain/lose nothing by them having or not having additional freedoms. Don't get me
288.
by Pyramus 5y ago
That is simply not true. The majority of Wirecard has been sold in the insolvency proceedings, e.g. the payments platform is still in use today! (Interestingly still using the domain wirecard.de!) The liquidation price was nowhere near its
289.
by Pyramus 5y ago
Having looked at a lot of the issues surrounding Tesla, I would strongly disagree with that statement. I think it's mostly informed by hindsight. While it remains speculative it is certainly possible that Tesla is in the same league as
290.
by Pyramus 5y ago
I don't think the original data is available. Re Norwegian data: https://www.elbil24.no/nyheter/elbiler-bulker-mest/71498210 https://cleantechnica.com/2018/06/04/electric-car-in
291.
by Pyramus 5y ago
> This is often quoted that tesla has a lower accident rate than other vehicles. In general Teslas have higher accident rates than comparable cars, partly because EVs have higher accidents rates in general, but even among EVs Teslas have
292.
by Pyramus 5y ago
Interestingly both statements are true. We are both in and leagues out of the dark ages. On average we have progressed tremendously over the last 200 years, say. That means for many diseases, we have made extraordinary progress, as eviden
293.
by Pyramus 5y ago
Parent's argument of the interactions between individual and population effects is not related to the current Covid vaccines (i.e. only trivially so, like any other vaccine/drug). In fact, because the population size in the phase
294.
by Pyramus 5y ago
Yes and no. Yes, obviously the drug development process is very complex and a lot of thought goes into interactions at the N=1 level. However, we are hardly at the point where drugs are developed for individuals, based on their genetic make
295.
by Pyramus 5y ago
> When I went looking for validation of it, I couldn't find any. It's unlikely you will find validation outside an entry-level text book for virology or epidemiology. From my understanding it's a fundamental assumption tha
296.
by Pyramus 5y ago
That's a valid argument if marketing was the primary decision maker in drug development. But that is not the case, at this very moment Merck is likely developing several potential drugs for Covid in parallel, and there is no guarantee
297.
by Pyramus 5y ago
I don't get it. So are you saying somebody else should go for EUA for ivermectin for Covid, and then Merck couldn't go for EUA for their new drug? Or are you saying Merck couldn't go for several EUAs for Covid at the same tim
298.
by Pyramus 5y ago
I don't get it, why would Merck leave money on the table. Merck has and will develop many more Covid drugs. It does not make sense to bet everything on one horse where there is a lot of uncertainty and risk that any drug will see the l
299.
by Pyramus 5y ago
So you are asserting they don't want to benefit from both?
300.
by Pyramus 5y ago
So did you know about the paper in question and if so how convinced are you of the claims/evidence in this specific case?

More ›